Interfering with HIV therapy

Research output: Contribution to journalReview article

Abstract

Type 1 interferon signaling promotes HIV persistence even during combined antiretroviral therapy.

Original languageEnglish (US)
Article numbereaal4987
JournalScience Translational Medicine
Volume9
Issue number371
DOIs
StatePublished - Jan 4 2017

Fingerprint

Interferon Type I
HIV
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Interfering with HIV therapy. / Lund, Amanda.

In: Science Translational Medicine, Vol. 9, No. 371, eaal4987, 04.01.2017.

Research output: Contribution to journalReview article

@article{41133bf0aea242b4ae3c0b0fc2ab66ec,
title = "Interfering with HIV therapy",
abstract = "Type 1 interferon signaling promotes HIV persistence even during combined antiretroviral therapy.",
author = "Amanda Lund",
year = "2017",
month = "1",
day = "4",
doi = "10.1126/scitranslmed.aal4987",
language = "English (US)",
volume = "9",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "371",

}

TY - JOUR

T1 - Interfering with HIV therapy

AU - Lund, Amanda

PY - 2017/1/4

Y1 - 2017/1/4

N2 - Type 1 interferon signaling promotes HIV persistence even during combined antiretroviral therapy.

AB - Type 1 interferon signaling promotes HIV persistence even during combined antiretroviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=85010683565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010683565&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aal4987

DO - 10.1126/scitranslmed.aal4987

M3 - Review article

C2 - 28053154

AN - SCOPUS:85010683565

VL - 9

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 371

M1 - eaal4987

ER -